Press Release Distribution
 

Members Login  |  Register  |  Why Join?   Subscribe to Newsletter Newsletter   RSS Feeds RSS Feeds

Video Releases    |    Pricing & Distribution Plans    |    Today's News    |    News By Category    |    News By Date    |    Business Directory
All Press Releases for January 10, 2013 »
RSS Feeds RSS Feed     Print this news Printer Friendly     Email this news Email It    Create PDF PDF Version   



Ateevia Botanica Is The New Daily Defense Cream Against Pain: Homeopathic Breakthrough Reduces Swelling and Inflammation
A new product has been lauched by Alquemiste LLC dedicated to relieving achy joints, muscle discomfort and inflammatory pain without narcotics, steroids, smelly ointments or skin-irritating ingredients. 
x-small text small text medium text large text


    CRESSKILL, NJ, January 10, 2013 /24-7PressRelease/ -- Alquemiste LLC, a leading provider of patented homeopathic remedies, has launched a product to address achy joints, muscle discomfort and inflammatory pain without narcotics, steroids, smelly ointments or skin-irritating ingredients.

PRIME Therapy is an all-natural topical pain reliever that reduces swelling and inflammation in joints and muscles in a short amount of time. Medical doctors, chiropractors and physical therapists recommend it to treat common pain conditions ranging from arthritis to carpal tunnel syndrome, and plantar fasciitis to sports strains, such as tennis elbow.

More Americans are affected by pain than diabetes, heart disease and cancer combined, according to the American Academy of Pain Medicine. "Muscle and joint inflammation can be incredibly painful," says Robert Kramer, vice president of marketing for Ateevia. "On a chronic level, it can cause significant physiological damage to the human body. Ateevia's PRIME is a daily defense cream against pain. It has the ability to shift the approach to inflammatory pain relief because the product is so safe; people tend to use it preventatively."

PRIME represents years of research and development by an anesthesiologist. Based upon his grandfather's formula, this physician refined the treatment to make it safer, stronger, and more effective.

The cream contains a blend of organic ingredients with anti-inflammatory properties: pumpkin seed and sunflower seed extract, along with borage, poke root and safflower oil. The natural phytonutrient power of the ingredients is enhanced by Ateevia's manufacturing process.

PRIME does not contain capsaicin, a common ingredient in many pain-relieving ointments that can irritate the skin. It does not interfere with other medications. It is applied 2-3 times a day (more if the pain is chronic), by massaging a nickel-sized amount into the skin until completely absorbed.

The cream is already proving to be clinically effective. An independent university study found the therapy helped decrease pain and improve mobility in chronic pain sufferers within the first week of use. Additionally, more than 85 percent of patients experienced significant relief within 4 weeks.

"Chronic pain can cause depression, insomnia and stress," Kramer says. "It can cause low self-esteem because a person is unable to be active. PRIME can reverse those effects by alleviating people's discomfort."

PRIME can be found in select pharmacies in New Jersey and New York and on Ateevia's website, http://www.ateevia.com. It will soon be available on Amazon.com and DrugStore.com.


---
Press release service and press release distribution provided by http://www.24-7pressrelease.com


# # #

Read more Press Releases from Danielle Betts:


Contact Information:
Danielle Betts
Maximum Exposure PR

Woodcliff Lake, New Jersey
USA
Voice: 201-573-0300
E-Mail: Email us Here
Website: Visit Our Website
Disclaimer:
If you have any questions regarding information in this press release, please contact the person listed in the contact module of this page. Please do not attempt to contact 24-7PressRelease. We are unable to assist you with any information regarding this release. 24-7PressRelease disclaims any content contained in this press release. Please see our complete Terms of Service disclaimer for more information.